간세포 성장 인자(HGF) 시장 : 제품 유형별, 유형별, 공급원별, 용도별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2025-2032년)

Hepatocyte Growth Factors (HGFs) Market size was valued at US$ 71,786.23 Million in 2024, expanding at a CAGR of 5.6% from 2025 to 2032.

The hepatocyte growth factors (HGFs) market refers to the global ecosystem of products, technologies, and services used in the research, development, manufacturing, and application of hepatocyte growth factors. HGFs are a class of proteins that are essential for liver regeneration, embryonic development, tissue repair, angiogenesis, and tumor growth. They are primarily used in regenerative medicine, oncology, cell-based therapies, preclinical drug testing, and organ transplantation studies. This market includes recombinant proteins, HGF gene therapies, and hepatocyte-based cell culture products for both therapeutic and research applications.

Hepatocyte Growth Factors (HGFs) Market- Market Dynamics

Rising Incidence of Chronic Diseases to Propel Market Demand

The increasing prevalence of chronic diseases is a major driver of the Hepatocyte Growth Factors (HGF) market. Conditions like liver cirrhosis, hepatitis, cardiovascular disorders, and chronic kidney disease are on the rise worldwide as a result of aging populations, sedentary lifestyles, and poor dietary habits. HGFs play a crucial role in tissue regeneration, repair, and cell growth, making them a valuable tool in treating these conditions. The growing demand for advanced regenerative treatments and biologics is driving research on HGF, clinical trials, and product development. As chronic diseases impose a significant burden on healthcare systems, the demand for effective, targeted therapies drives market growth. In the United States, the Centers for Disease Control and Prevention (CDC) reported in 2024 that approximately 42% of adults have two or more chronic conditions, with 12% having at least five. These conditions account for about 90% of the nation's annual $4.1 trillion healthcare expenditure

Hepatocyte Growth Factors (HGFs) Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.6% over the forecast period (2025-2032)

Based on product type segmentation, HGF gene therapy is the fastest growing segment in the market

Based on Source segmentation, human-derived is the leading Source in 2025

Based on application segmentation, Oncology is the rapidly expanding segment the leading application in 2025

Based on End User segmentation, Pharmaceutical & Biotechnology Companies is the leading End User in 2025

On the basis of region, North America was the leading revenue generator in 2025

Hepatocyte Growth Factors (HGFs) Market- Segmentation Analysis:

The Global Hepatocyte Growth Factors (HGFs) Market is segmented on the basis of Product Type, Type, Source, Application, End User, and Region.

The market is divided into five categories based on product type: Recombinant Hepatocyte Growth Factors, Natural HGFs (Purified from Biological Sources), Synthetic Peptide Derivatives, HGF Gene Therapy Products, and Others. The HGF gene therapy products segment is expected to grow the fastest in the coming years, owing to their ability to provide targeted and effective treatment, particularly in regenerative medicine and oncology. Gene therapy allows for direct delivery of HGF to specific cells or tissues, which can reduce side effects and improve therapeutic efficacy. Techniques such as CRISPR-Cas9 enable precise gene modifications, resulting in more effective HGF gene therapies. The positive results of Phase III clinical trials involving HGF gene therapy are boosting investor confidence and encouraging additional research and development.

The market is divided into four categories based on Source: Human-Derived, Animal-Derived, Synthetic/Engineered Sources, and Others. The human-derived segment is expected to dominate the market in 2025, driven by its increased relevance and potential for clinical applications, particularly in regenerative medicine and the treatment of diseases such as liver damage. Human-derived HGFs are naturally produced by the body and are essential for various physiological processes, including liver regeneration, tissue repair, and cell proliferation. They have shown potential for treating liver diseases, heart failure, and neurological disorders. Human-derived HGFs are preferred for clinical trials and therapeutic use because they are biocompatible with the human body. Furthermore, advances in genetic engineering and stem cell technology have reinforced this leadership, allowing for the development of more effective and precisely targeted HGF therapies.

Hepatocyte Growth Factors (HGFs) Market- Geographical Insights

North America dominates the hepatocyte growth factor (HGF) market, with the largest share expected in 2025, owing to its advanced biotech industry and supportive regulatory environment. The increasing awareness of HGF's potential benefits, combined with an aging population and rising chronic disease prevalence, has fueled demand for HGFs. The region's robust healthcare system, strong emphasis on R&D, and presence of leading pharmaceutical and biotech companies have all aided market growth.

The Asia Pacific region is experiencing the most rapid growth, driven by rising chronic disease rates, expanded healthcare infrastructure, and increased healthcare spending. The governments of several Asian countries actively promote pharmaceutical development and research through funding, regulatory streamlining, and incentives for clinical trials. Clinical trials in this region are typically less expensive than those in Western countries, attracting international pharmaceutical companies. The region's large population base provides easy access to numerous potential clinical trial participants.

Hepatocyte Growth Factors (HGFs) Market- Competitive Landscape:

The competitive landscape of the hepatocyte growth factor market is characterized by the presence of several key players involved in the research, development, and commercialization of HGF products. These companies strive for a competitive advantage through innovation, strategic partnerships, and expansion into emerging markets. The market is characterized by a mix of established pharmaceutical firms, biotechnology companies, and research institutions, all of which contribute to the advancement of HGF applications across a variety of therapeutic areas. The market's dynamic nature encourages ongoing research and development to improve product efficacy, safety, and market reach. Amgen Inc., Genentech Inc., and Eli Lilly and Company are among the leading players in the hepatocyte growth factor market.

Recent Developments:

In May 2023, AnGes submitted a marketing application to the Ministry of Health, Labour, and Welfare for its gene therapy product, Collategene, which is intended to treat leg ulcers caused by chronic arterial occlusion. Following conditional approval in March 2019, this new application now seeks full approval based on the evaluation results. If approved, Collategene will be the first product to have its conditions removed since Japan implemented the regenerative medicine approval system.

In July 2023: Lonza had an agreement with ABL Bio, a pioneering Korean biologics company with a focus on bispecific antibodies for immuno-oncology and neurodegenerative diseases. The collaboration agreement between Lonza and ABL Bio supports the development and manufacturing of ABL Bio's new bispecific antibody product.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Thermo Fisher Scientific
• YooYoung Pharmaceutical Co., Ltd.
• F-star Therapeutics Inc.
• Creative BioMart
• ACROBiosystems
• Kringle Pharma
• Lonza Group
• Galaxy Bio Tech
• Merck KGaA (MilliporeSigma)
• F. Hoffmann-La Roche Ltd
• Galaxy Bio Tech
• Sino Biological Inc.
• Cell Signaling Technology
• R&D Systems (Bio-Techne)
• Origene Technologies
• Takara Bio Inc.
• GenScript Biotech Corporation
• Miltenyi Biotec
• BioVision Inc.
• Creative Biolabs
• Eli Lilly and Company (for gene therapy pipelines involving HGF)
• Others

GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

• Recombinant Hepatocyte Growth Factors
• HGF Gene Therapy Products
• Synthetic Peptide Derivatives
• Natural HGFs (Purified from Biological Sources)
• Others
• Fusion Proteins
• Hybrid Growth Factors

GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

• Preclinical
• Phase III (Ongoing)
• Phase II (Approved)
• Phase II (Ongoing)
• Phase I

GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

• Human-Derived
• Synthetic/Engineered Sources
• Animal-Derived
• Others
• Chimeric or Hybrid Constructs

GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Regenerative Medicine
• Liver Regeneration
• Kidney Repair
• Wound Healing
• Cell Therapy & Stem Cell Research
• Toxicology and Preclinical Drug Testing
• Organ Transplantation Support
• Others
• Neurodegenerative Diseases
• Pulmonary Fibrosis
• Oncology
• Cancer Stem Cell Research
• Tumor Metastasis Studies

GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

• Pharmaceutical & Biotechnology Companies
• CROs (Contract Research Organizations
• Academic & Research Institutes
• Hospitals & Transplant Centers
• Others
• Diagnostic Labs
• Private Stem Cell Banks

GLOBAL HEPATOCYTE GROWTH FACTORS (HGFS) MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Hepatocyte Growth Factors (HGFs) Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Hepatocyte Growth Factors (HGFs) Market Snippet by Product Type
  • 2.1.2. Hepatocyte Growth Factors (HGFs) Market Snippet by Type
  • 2.1.3. Hepatocyte Growth Factors (HGFs) Market Snippet by Source
  • 2.1.4. Hepatocyte Growth Factors (HGFs) Market Snippet by Application
  • 2.1.5. Hepatocyte Growth Factors (HGFs) Market Snippet by End User
  • 2.1.6. Hepatocyte Growth Factors (HGFs) Market Snippet by Country
  • 2.1.7. Hepatocyte Growth Factors (HGFs) Market Snippet by Region
• 2.2. Competitive Insights

3. Hepatocyte Growth Factors (HGFs) Key Market Trends

• 3.1. Hepatocyte Growth Factors (HGFs) Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Hepatocyte Growth Factors (HGFs) Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Hepatocyte Growth Factors (HGFs) Market Opportunities
• 3.4. Hepatocyte Growth Factors (HGFs) Market Future Trends

4. Hepatocyte Growth Factors (HGFs) Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Hepatocyte Growth Factors (HGFs) Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Hepatocyte Growth Factors (HGFs) Market Landscape

• 6.1. Hepatocyte Growth Factors (HGFs) Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Hepatocyte Growth Factors (HGFs) Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
  • 7.1.2. Recombinant Hepatocyte Growth Factors
  • 7.1.3. HGF Gene Therapy Products
  • 7.1.4. Synthetic Peptide Derivatives
  • 7.1.5. Natural HGFs (Purified from Biological Sources)
  • 7.1.6. Others
    • 7.1.6.1. Fusion Proteins
    • 7.1.6.2. Hybrid Growth Factors

8. Hepatocyte Growth Factors (HGFs) Market - By Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 8.1.1.1. Preclinical
    • 8.1.1.2. Phase III (Ongoing)
    • 8.1.1.3. Phase II (Approved)
    • 8.1.1.4. Phase II (Ongoing)
    • 8.1.1.5. Phase I

9. Hepatocyte Growth Factors (HGFs) Market - By Source

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
    • 9.1.1.1. Human-Derived
    • 9.1.1.2. Synthetic/Engineered Sources
    • 9.1.1.3. Animal-Derived
    • 9.1.1.4. Others
    • 9.1.1.4.1. Chimeric or Hybrid Constructs

10. Hepatocyte Growth Factors (HGFs) Market - By Application

• 10.1. Overview
  • 10.1.1.1. Regenerative Medicine
  • 10.1.1.1.1. Liver Regeneration
  • 10.1.1.1.2. Kidney Repair
  • 10.1.1.1.3. Wound Healing
  • 10.1.1.2. Cell Therapy & Stem Cell Research
  • 10.1.1.3. Toxicology and Preclinical Drug Testing
  • 10.1.1.4. Organ Transplantation Support
  • 10.1.1.5. Others
  • 10.1.1.5.1. Neurodegenerative Diseases
  • 10.1.1.5.2. Pulmonary Fibrosis
  • 10.1.1.6. Oncology
  • 10.1.1.6.1. Cancer Stem Cell Research
  • 10.1.1.6.2. Tumor Metastasis Studies

11. Hepatocyte Growth Factors (HGFs) Market - By End User

• 11.1. Overview
  • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.1.1. Pharmaceutical & Biotechnology Companies
    • 11.1.1.2. CROs (Contract Research Organizations
    • 11.1.1.3. Academic & Research Institutes
    • 11.1.1.4. Hospitals & Transplant Centers
    • 11.1.1.5. Others
    • 11.1.1.5.1. Diagnostic Labs
    • 11.1.1.5.2. Private Stem Cell Banks

12. Hepatocyte Growth Factors (HGFs) Market- By Geography

• 12.1. Introduction
  • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 12.2. North America
  • 12.2.1. Overview
  • 12.2.2. Hepatocyte Growth Factors (HGFs) Key Manufacturers in North America
  • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 12.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 12.2.6. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.2.9. U.S.
    • 12.2.9.1. Overview
    • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.9.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.2.9.5. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.2.10. Canada
    • 12.2.10.1. Overview
    • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.10.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.2.10.5. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 12.3. Europe
  • 12.3.1. Overview
  • 12.3.2. Hepatocyte Growth Factors (HGFs) Key Manufacturers in Europe
  • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 12.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 12.3.6. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.9. Germany
    • 12.3.9.1. Overview
    • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.9.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.9.5. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.10. UK
    • 12.3.10.1. Overview
    • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.10.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.10.5. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.11. France
    • 12.3.11.1. Overview
    • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.11.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.11.5. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.12. Italy
    • 12.3.12.1. Overview
    • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.12.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.12.5. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.13. Spain
    • 12.3.13.1. Overview
    • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.13.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.13.5. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.14. The Netherlands
    • 12.3.14.1. Overview
    • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.14.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.14.5. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.15. Sweden
    • 12.3.15.1. Overview
    • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.15.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.15.5. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.16. Russia
    • 12.3.16.1. Overview
    • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.16.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.16.5. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.17. Poland
    • 12.3.17.1. Overview
    • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.17.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.17.5. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.18. Rest of Europe
    • 12.3.18.1. Overview
    • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 12.4. Asia Pacific (APAC)
  • 12.4.1. Overview
  • 12.4.2. Hepatocyte Growth Factors (HGFs) Key Manufacturers in Asia Pacific
  • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 12.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 12.4.6. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  • 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.9. China
    • 12.4.9.1. Overview
    • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.9.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.9.5. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.10. India
    • 12.4.10.1. Overview
    • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.10.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.10.5. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.11. Japan
    • 12.4.11.1. Overview
    • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.11.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.11.5. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.12. South Korea
    • 12.4.12.1. Overview
    • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.12.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.12.5. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.13. Australia
    • 12.4.13.1. Overview
    • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.13.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.13.5. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.14. Indonesia
    • 12.4.14.1. Overview
    • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.14.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.14.5. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.15. Thailand
    • 12.4.15.1. Overview
    • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.15.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.15.5. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.16. Philippines
    • 12.4.16.1. Overview
    • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.16.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.16.5. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.17. Rest of APAC
    • 12.4.17.1. Overview
    • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.17.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.17.5. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 12.5. Latin America (LATAM)
  • 12.5.1. Overview
  • 12.5.2. Hepatocyte Growth Factors (HGFs) Key Manufacturers in Latin America
  • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 12.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 12.5.6. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  • 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.9. Brazil
    • 12.5.9.1. Overview
    • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.9.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.9.5. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.10. Mexico
    • 12.5.10.1. Overview
    • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.10.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.10.5. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.11. Argentina
    • 12.5.11.1. Overview
    • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.11.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.11.5. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.12. Colombia
    • 12.5.12.1. Overview
    • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.12.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.12.5. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.13. Rest of LATAM
    • 12.5.13.1. Overview
    • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 12.6. Middle East and Africa
  • 12.6.1. Overview
  • 12.6.2. Hepatocyte Growth Factors (HGFs) Key Manufacturers in Middle East and Africa
  • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 12.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 12.6.6. Middle East and Africa Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.9. Saudi Arabia
    • 12.6.9.1. Overview
    • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.10. United Arab Emirates
    • 12.6.10.1. Overview
    • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.11. Israel
    • 12.6.11.1. Overview
    • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.11.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.11.5. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.12. Turkey
    • 12.6.12.1. Overview
    • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.12.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.12.5. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.13. Algeria
    • 12.6.13.1. Overview
    • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.13.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.13.5. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.14. Egypt
    • 12.6.14.1. Overview
    • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.14.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.14.5. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.15. Rest of MEA
    • 12.6.15.1. Overview
    • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.15.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.15.5. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Hepatocyte Growth Factors (HGFs) Industry

• 13.1. Competitive Benchmarking
  • 13.1.1. Competitive Dashboard
  • 13.1.2. Competitive Positioning
• 13.2. Company Profiles
  • 13.2.1. Thermo Fisher Scientific
  • 13.2.2. YooYoung Pharmaceutical Co., Ltd.
  • 13.2.3. F-star Therapeutics Inc.
  • 13.2.4. Creative BioMart
  • 13.2.5. ACROBiosystems
  • 13.2.6. Kringle Pharma
  • 13.2.7. Lonza Group
  • 13.2.8. Galaxy Bio Tech
  • 13.2.9. Merck KGaA (MilliporeSigma)
  • 13.2.10. F. Hoffmann-La Roche Ltd
  • 13.2.11. Galaxy Bio Tech
  • 13.2.12. Sino Biological Inc.
  • 13.2.13. Cell Signaling Technology
  • 13.2.14. R&D Systems (Bio-Techne)
  • 13.2.15. Origene Technologies
  • 13.2.16. Takara Bio Inc.
  • 13.2.17. GenScript Biotech Corporation
  • 13.2.18. Miltenyi Biotec
  • 13.2.19. BioVision Inc.
  • 13.2.20. Creative Biolabs
  • 13.2.21. Eli Lilly and Company (for gene therapy pipelines involving HGF)
  • 13.2.22. Others

14. 360 Degree Analyst View

15. Appendix

• 15.1. Research Methodology
• 15.2. References
• 15.3. Abbreviations
• 15.4. Disclaimer
• 15.5. Contact Us